# Physical Activity Levels and Statin Therapy

> **NCT05625945** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 196 (actual)

## Conditions studied

- Cardiovascular Diseases
- HMG COA Reductase Inhibitor Adverse Reaction
- Muscle Pain

## Interventions

- **BEHAVIORAL:** Physical activity monitoring

## Key facts

- **NCT ID:** NCT05625945
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2023-11-16
- **Final completion:** 2023-11-16
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05625945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05625945, "Physical Activity Levels and Statin Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05625945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*